BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol. 1999;94:169-177. [PMID: 9934750 DOI: 10.1111/j.1572-0241.1999.00790.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Houlihan DD, Newsome PN. Critical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease. Gastroenterology 2008;135:438-50. [DOI: 10.1053/j.gastro.2008.05.040] [Cited by in Crossref: 137] [Cited by in F6Publishing: 113] [Article Influence: 10.5] [Reference Citation Analysis]
2 Skowrońska M, Albrecht J. Oxidative and nitrosative stress in ammonia neurotoxicity. Neurochem Int 2013;62:731-7. [PMID: 23142151 DOI: 10.1016/j.neuint.2012.10.013] [Cited by in F6Publishing: 48] [Reference Citation Analysis]
3 Mccarty M. Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Medical Hypotheses 2000;55:289-93. [DOI: 10.1054/mehy.1999.1032] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
4 Pijls KE, Jonkers DM, Elamin EE, Masclee AA, Koek GH. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver Int. 2013;33:1457-1469. [PMID: 23879434 DOI: 10.1111/liv.12271] [Cited by in Crossref: 44] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
5 Deng W, Duan M, Qian B, Zhu Y, Lin J, Zheng L, Zhang C, Qi X, Luo M. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats. Clin Res Hepatol Gastroenterol 2019;43:255-65. [PMID: 30413372 DOI: 10.1016/j.clinre.2018.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin SY, Wang YY, Sheu WH. Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis. Metabolism. 2004;53:922-926. [PMID: 15254888 DOI: 10.1016/j.metabol.2004.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
7 Horiike N, Abe M, Kumagi T, Hiasa Y, Akbar SM, Michitaka K, Onji M. The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases. Clin Biochem. 2005;38:531-534. [PMID: 15885232 DOI: 10.1016/j.clinbiochem.2005.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
8 Federico A, Dallio M, Godos J, Loguercio C, Salomone F. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Transl Res. 2016;167:116-124. [PMID: 26318867 DOI: 10.1016/j.trsl.2015.08.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
9 Nakatani Y, Fukui H, Kitano H, Nagamoto I, Tsujimoto T, Kuriyama S, Kikuchi E, Hoppou K, Tsujii T. Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. Liver. 2001;21:64-70. [PMID: 11169075 DOI: 10.1034/j.1600-0676.2001.210110.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
10 Kramer L, Gendo A, Madl C, Ferrara I, Funk G, Schenk P, Sunder-Plassmann G, Hörl WH. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis. 2000;36:1193-1200. [PMID: 11096044 DOI: 10.1053/ajkd.2000.19834] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
11 Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther. 2001;89:273-293. [PMID: 11516480 DOI: 10.1016/s0163-7258(01)00128-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
12 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol. 2006;12:2563-2568. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16] [Reference Citation Analysis]
13 Bruha R, Vitek L, Petrtyl J, Lenicek M, Urbanek P, Zelenka J, Jachymova M, Svestka T, Kalab M, Dousa M, Marecek Z. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes. Scandinavian Journal of Gastroenterology 2009;41:1454-63. [DOI: 10.1080/00365520600780403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
14 Tazi KA, Moreau R, Hervé P, Dauvergne A, Cazals-Hatem D, Bert F, Poirel O, Rabiller A, Lebrec D. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology. 2005;129:303-314. [PMID: 16012955 DOI: 10.1053/j.gastro.2005.04.016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
15 Zhang Q, Yang F, Li X, Wang LW, Chu XG, Zhang H, Gong ZJ. Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB. Inflammation 2015;38:1364-73. [PMID: 25604312 DOI: 10.1007/s10753-014-0108-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
16 Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Christos P, Paraskevi K, Konstantinos P, Katsaraki A, Tsianos EV. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci. 2005;50:1771-1777. [PMID: 16187171 DOI: 10.1007/s10620-005-2935-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Tsai CF, Chu CJ, Huang YH, Wang YP, Liu PY, Lin HC, Lee FY, Lu CL. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. PLoS One. 2015;10:e0128437. [PMID: 26039496 DOI: 10.1371/journal.pone.0128437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lin SY, Wang YY, Sheu WH. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis. Clin Endocrinol (Oxf). 2002;57:805-811. [PMID: 12460331 DOI: 10.1046/j.1365-2265.2002.01672.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
19 Brands MW, Lee DL. Psychosocial Stress and Hypertension. Comprehensive Hypertension. Elsevier; 2007. pp. 501-11. [DOI: 10.1016/b978-0-323-03961-1.50045-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Sánchez E, Francés R, Soriano G, Mirelis B, Sancho FJ, González-Navajas JM, Muñoz C, Song XY, Pérez-Mateo M, Such J, Guarner C. Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis. PLoS One 2013;8:e59692. [PMID: 23527251 DOI: 10.1371/journal.pone.0059692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Jover R, Rodrigo R, Felipo V, Insausti R, Sáez-Valero J, García-Ayllón MS, Suárez I, Candela A, Compañ A, Esteban A, Cauli O, Ausó E, Rodríguez E, Gutiérrez A, Girona E, Erceg S, Berbel P, Pérez-Mateo M. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1257-66. [PMID: 16729306 DOI: 10.1002/hep.21180] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 7.1] [Reference Citation Analysis]
22 Chen TA, Tsao YC, Chen A, Lo GH, Lin CK, Yu HC, Cheng LC, Hsu PI, Tsai WL. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:619-625. [PMID: 19191184 DOI: 10.1080/00365520902719273] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
23 Mani AR, Montagnese S, Jackson CD, Jenkins CW, Head IM, Stephens RC, Moore KP, Morgan MY. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2009;296:G330-G338. [PMID: 19023029 DOI: 10.1152/ajpgi.90488.2008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
24 Zhang SC, Zheng YH, Yu PP, Min TH, Yu FX, Ye C, Xie YK, Zhang QY. Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6. World J Gastroenterol 2012;18:3696-704. [PMID: 22851861 DOI: 10.3748/wjg.v18.i28.3696] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
25 Girón-González JA, Martínez-Sierra C, Rodriguez-Ramos C, Rendón P, Macías MA, Fernández-Gutiérrez C, Díaz F, Martín-Herrera L. Adhesion molecules as a prognostic marker of liver cirrhosis. Scand J Gastroenterol. 2005;40:217-224. [PMID: 15764154 DOI: 10.1080/00365520510011470] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
26 Papadopoulos N, Soultati A, Goritsas C, Lazaropoulou C, Achimastos A, Adamopoulos A, Dourakis SP. Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection? J Clin Gastroenterol. 2010;44:713-719. [PMID: 20495469 DOI: 10.1097/mcg.0b013e3181d47f71] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol. 2009;43:272-279. [PMID: 18562979 DOI: 10.1097/mcg.0b013e31815e7f58] [Cited by in Crossref: 107] [Cited by in F6Publishing: 52] [Article Influence: 8.9] [Reference Citation Analysis]
28 Nissen P, Van Lieshout JJ, Novovic S, Bundgaard-nielsen M, Secher NH. Techniques of cardiac output measurement during liver transplantation: Arterial pulse wave versus thermodilution: Cardiac Output During Liver Transplantation. Liver Transpl 2009;15:287-91. [DOI: 10.1002/lt.21689] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
29 Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2017;29:1109-17. [DOI: 10.1097/meg.0000000000000940] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
30 Rodriguez-Ramos C, Galan F, Diaz F, Elvira J, Martin-Herrera L, Giron-Gonzalez JA. Expression of proinflammatory cytokines and gheir inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci. 2001;46:1668-1676. [PMID: 11508666 DOI: 10.1023/a:1010645302750] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
31 Genescà J, Buti M. Citocinas y cirrosis hepática. Medicina Clínica 2004;122:457-8. [DOI: 10.1016/s0025-7753(04)74271-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, Peralta C, Soriano G, Pappas J, Runyon BA. Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001;46:2360-6. [PMID: 11713936 DOI: 10.1023/a:1012342929326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
33 Genescà J, Martí R, Rojo F, Campos F, Peribáñez V, Gónzalez A, Castells L, Ruiz-Marcellán C, Margarit C, Esteban R, Guardia J, Segura R. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003;52:1054-9. [PMID: 12801966 DOI: 10.1136/gut.52.7.1054] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
34 Lee S, Son SC, Han MJ, Kim WJ, Kim SH, Kim HR, Jeon WK, Park KH, Shin MG. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol. 2008;14:3884-3890. [PMID: 18609714 DOI: 10.3748/wjg.14.3884] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
35 Yannaki E, Anagnostopoulos A, Kapetanos D, Xagorari A, Iordanidis F, Batsis I, Kaloyannidis P, Athanasiou E, Dourvas G, Kitis G. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol. 2006;34:1583-1587. [PMID: 17046578 DOI: 10.1016/j.exphem.2006.06.012] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
36 Kalambokis G, Kostoula A, Economou M, Tsianos EV. Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites. Clin Chem 2005;51:2207-8. [PMID: 16244306 DOI: 10.1373/clinchem.2005.053058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
37 Sheikh MY, Javed U, Singh J, Choudhury J, Deen O, Dhah K, Peterson MW. Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis. Dig Dis Sci 2009;54:2706-11. [PMID: 19117129 DOI: 10.1007/s10620-008-0664-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
38 Petrtyl J, Dvorak K, Jachymova M, Vitek L, Lenicek M, Urbanek P, Linhart A, Jansa P, Bruha R. Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis. Scand J Gastroenterol 2013;48:592-601. [PMID: 23452051 DOI: 10.3109/00365521.2013.773459] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Bengmark S. Acute and "chronic" phase reaction-a mother of disease. Clin Nutr 2004;23:1256-66. [PMID: 15556248 DOI: 10.1016/j.clnu.2004.07.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
40 Kurtovic J, Boyle M, Bihari D, Riordan SM. Nitric-oxide-lowering effect of terlipressin in decompensated cirrhosis: comparison to the molecular adsorbent recirculating system and correlation with clinical status. European Journal of Gastroenterology & Hepatology 2004;16:1335-8. [DOI: 10.1097/00042737-200412000-00017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
41 Theodorakis NG, Wang Y, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmann JV. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 2003;124:1500-8. [DOI: 10.1016/s0016-5085(03)00280-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
42 Rao VL. Nitric oxide in hepatic encephalopathy and hyperammonemia. Neurochemistry International 2002;41:161-70. [DOI: 10.1016/s0197-0186(02)00038-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
43 Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol. 2006;67:27-32. [PMID: 16698422 DOI: 10.1016/j.humimm.2006.02.025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
44 Kramer L, Hörl WH. Hepatorenal syndrome. Seminars in Nephrology 2002;22:290-301. [DOI: 10.1053/snep.2002.33670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
45 Arranz J, Soriano A, Garcia I, García I, Concepción MT, Navarro J, Arteaga A, Filella X, Bravo P, Barrera M. Effect of proinflammatory cytokines (IL-6, TNF-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc. 2003;35:1884-1887. [PMID: 12962834 DOI: 10.1016/s0041-1345(03)00603-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
46 Elsing C, Harenberg S, Stremmel W, Herrmann T. Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol 2007;13:421-5. [PMID: 17230612 DOI: 10.3748/wjg.v13.i3.421] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
47 Gunji H, Little RA, Hiraiwa K. Interleukin-6 deficiency increases blood volume without altering body composition in young mice. Cytokine 2002;20:30-7. [PMID: 12441144 DOI: 10.1006/cyto.2002.1977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
48 Dong T, Aronsohn A, Gautham Reddy K, Te HS. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci 2016;61:3621-6. [DOI: 10.1007/s10620-016-4313-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
49 de Oca Arjona MM, Marquez M, Soto MJ, Rodriguez-Ramos C, Terron A, Vergara A, Arizcorreta A, Fernandez-Gutierrez C, Giron-González JA. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality. J Acquir Immune Defic Syndr. 2011;56:420-427. [PMID: 21266909 DOI: 10.1097/qai.0b013e31820ef408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
50 Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol. 2005;39:540-543. [PMID: 15942443 DOI: 10.1097/01.mcg.0000165671.25272.0f] [Cited by in Crossref: 297] [Cited by in F6Publishing: 277] [Article Influence: 18.6] [Reference Citation Analysis]
51 Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010;2:208-20. [PMID: 21160999 DOI: 10.4254/wjh.v2.i6.208] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
52 Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42:195-201. [PMID: 15664244 DOI: 10.1016/j.jhep.2004.10.019] [Cited by in Crossref: 324] [Cited by in F6Publishing: 284] [Article Influence: 20.3] [Reference Citation Analysis]
53 Caro E, Francés R, Zapater P, Pascual S, Bellot P, Such J. Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis. Liver Int 2016;36:1473-80. [PMID: 26991936 DOI: 10.1111/liv.13118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
54 Nelson RS, Eichinger MR. Role of nitric oxide (NO) in pulmonary dysfunction associated with experimental cirrhosis. Respiration Physiology 2001;126:65-74. [DOI: 10.1016/s0034-5687(00)00227-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Brito-azevedo A, Perez RM, Maranhão PA, Coelho HS, Fernandes ES, Castiglione RC, de Souza MD, Villela-nogueira CA, Bouskela E. Organ dysfunction in cirrhosis: a mechanism involving the microcirculation. European Journal of Gastroenterology & Hepatology 2019;31:618-25. [DOI: 10.1097/meg.0000000000001366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
56 Giannitrapani L, Cervello M, Soresi M, Notarbartolo M, La Rosa M, Virruso L, D'Alessandro N, Montalto G. Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:46-52. [PMID: 12095927 DOI: 10.1111/j.1749-6632.2002.tb04093.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
57 Merkel C, Escorsell A, Sieber CC, Lee F, Groszrnann RJ. Session 4 - Preprimary Prophylaxis: Can (and Should) We Prevent the Formation and Growth of Varices? In: de Franchis R, editor. Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science Ltd; 2001. pp. 97-111. [DOI: 10.1002/9780470760154.ch7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Matsumi M, Takahashi T, Fujii H, Ohashi I, Kaku R, Nakatsuka H, Shimizu H, Morita K, Hirakawa M, Inagaki M, Sadamori H, Yagi T, Tanaka N, Akagi R. Increased heme oxygenase-1 gene expression in the livers of patients with portal hypertension due to severe hepatic cirrhosis. J Int Med Res. 2002;30:282-288. [PMID: 12166345 DOI: 10.1177/147323000203000309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
59 Al-naamani N, Roberts KE. Portopulmonary Hypertension. Clinics in Chest Medicine 2013;34:719-37. [DOI: 10.1016/j.ccm.2013.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Wang X, Zhong YX, Zhang ZY, Lu J, Lan M, Miao JY, Guo XG, Shi YQ, Zhao YQ, Ding J. Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. World J Gastroenterol. 2002;8:328-332. [PMID: 11925618 DOI: 10.3748/wjg.v8.i2.328] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Lee DL, Sturgis LC, Labazi H, Osborne JB Jr, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 2006;290:H935-40. [PMID: 16284237 DOI: 10.1152/ajpheart.00708.2005] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 10.3] [Reference Citation Analysis]
62 Leithead JA, Hayes PC, Ferguson JW. Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction. Aliment Pharmacol Ther. 2014;39:699-711. [PMID: 24528130 DOI: 10.1111/apt.12653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
63 Garcia-Martinez R, Noiret L, Sen S, Mookerjee R, Jalan R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int. 2015;35:335-343. [PMID: 24620819 DOI: 10.1111/liv.12528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
64 Mitchell R, McDermid J, Ma MM, Chik CL. MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol. 2011;3:157-163. [PMID: 21860675 DOI: 10.4254/wjh.v3.i6.157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
65 Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003;37:1154-1164. [PMID: 12717397 DOI: 10.1053/jhep.2003.50180] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 6.4] [Reference Citation Analysis]
66 Hanai T, Shiraki M, Nishimura K, Imai K, Suetsugu A, Takai K, Shimizu M, Naiki T, Moriwaki H. Free fatty acid as a marker of energy malnutrition in liver cirrhosis. Hepatol Res. 2014;44:218-228. [PMID: 23601060 DOI: 10.1111/hepr.12112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
67 Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol 2006;12:2563-8. [PMID: 16688802 DOI: 10.3748/wjg.v12.i16.2563] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
68 Porowski D, Wirkowska A, Hryniewiecka E, Wyzgał J, Pacholczyk M, Pączek L. Liver Failure Impairs the Intrahepatic Elimination of Interleukin-6, Tumor Necrosis Factor-Alpha, Hepatocyte Growth Factor, and Transforming Growth Factor-Beta. Biomed Res Int 2015;2015:934065. [PMID: 26090463 DOI: 10.1155/2015/934065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
69 Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 2004;40:327-30. [PMID: 14739106 DOI: 10.1016/j.jhep.2003.12.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
70 Bhimani EK, Serracino-Inglott F, Sarela AI, Batten JJ, Mathie RT. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis. J Surg Res. 2003;113:172-178. [PMID: 12943827 DOI: 10.1016/s0022-4804(03)00163-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
71 Montes-de-Oca M, Blanco MJ, Marquez M, Soto MJ, Fernandez-Gutiérrez C, Rodriguez-Ramos C, Giron-Gonzalez JA. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Liver Int. 2011;31:850-858. [PMID: 21645216 DOI: 10.1111/j.1478-3231.2011.02505.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
72 Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396-407. [PMID: 24751830 DOI: 10.1016/j.jhep.2014.04.012] [Cited by in Crossref: 193] [Cited by in F6Publishing: 162] [Article Influence: 27.6] [Reference Citation Analysis]